Skip to main content
ATRA logo
ATRA
(NASDAQ)
Atara Biotherapeutics, Inc.
$4.99-- (--)
Loading... - Market loading

Atara Biotherapeutics (ATRA) Stock Price & Financial Analysis

Atara Biotherapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$4.87 - $5.26
52-Week High$19.15
52-Week Low$3.92
Open$5.00
Volume46.93K
Average Volume (3M)46.93K
Market Cap67.68M
Shares Outstanding13.56M
P/E Ratio (TTM)3.00
Price to Sales (P/S)0.46
EV/EBITDA2.98
Revenue (TTM)151.93M
Net Income (TTM)23.40M
Free Cash Flow (TTM)-69.80M
EPS (TTM)$1.73
Profit Margin15.40%
Operating Margin17.64%
50-Day MA$5.08
200-Day MA$10.75
52-Week Change-13.98%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Atara Biotherapeutics

What is the current stock price for ATRA?

As of the latest trading session, ATRA stock trades at $4.99. The 52-week range is $3.92–$19.15, with a day range of $4.87–$5.26.

What is the P/E ratio for ATRA?

Atara Biotherapeutics's trailing P/E ratio is 3.0, meaning investors pay $3.0 for every $1 of annual earnings. Atara Biotherapeutics operates in the Healthcare sector.

Does ATRA pay dividends?

Atara Biotherapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ATRA?

Based on 2 analysts, the consensus for ATRA is Sell. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ATRA?

Atara Biotherapeutics's market capitalization is $67.7M, classifying it as a micro-cap company. Atara Biotherapeutics operates in the Healthcare sector within the Biotechnology industry.